Slaughter and May advised Reckitt Benckiser Group plc on the update of its EMTN Programme and subsequent issuances thereunder
Slaughter and May advised Reckitt Benckiser Group plc (“Reckitt”) on the update of its £10,000,000,000 Euro Medium Term Note programme (the “Programme”), the establishment of which Slaughter and May advised on last year. Under the Programme, Reckitt Benckiser Treasury Services plc has the ability to issue notes guaranteed by Reckitt which are admitted to trading on the Main Market of the London Stock Exchange.
Immediately following the Programme update, Slaughter and May additionally advised Reckitt on the following issuances:
€900,000,000 3.625% Fixed Rate Senior Notes due 20 June 2029; and
£300,000,000 5.000% Fixed Rate Senior Notes due 20 December 2032.
Slaughter and May worked closely with Ambika Chauhan (Legal Director, CHQ Functions and Global Indirect Procurement – Group Legal Affairs) throughout.
Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Biofreeze, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more.
